Tag Archives: clinical management course

Clinical research for Hair Treatment

Clinical research for Hair Treatment

Treatments for the various forms of losing hairs have on moderate success. Three medicines have proof to back up their use in hair thinning locks loss: finasteride, dutasteride and minoxidil. They generally work better to prevent further losing locks than to replenish lost locks.

They may be used together when losing hairs is progressive or further restoration is desired after 12 several weeks. Other medicines include ketoconazole, and in female androgenic hair loss spironolactone and flutamide. Mixtures of finasteride, minoxidil and ketoconazole are more efficient than individual use.

Finasteride

Finasteride is used to treat hair thinning losing locks. Therapy provides about 30% improvement in losing locks after six several weeks of treatment, and effectiveness only continues as long as the drug is taken. There is no good proof for its use ladies.

It may cause man boobs, male impotence and depression.

Dutasteride

Dutasteride is used off label for hair thinning losing hairs.

Minoxidil

Minoxidil, applied topically, is widely used for the treatments for losing locks. It will work in helping promote growth of hir in both individuals with androgenic hair loss. About 40% of men experience growth of hir after 3–6 several weeks. It is the only topical product that is FDA approved for androgenic losing locks.

Ketoconazole

Ketoconazole may help ladies.

Spironolactone

There is tenative assistance for spironolactone ladies. Due to its feminizing adverse reactions and risk of sterility in men it is not often used in men. It can also cause hypotension, hyperkalemia, and cardiac dysrhythmia. Also, ladies who are expecting or trying to conceive generally cannot use the medication as it is a teratogen, and can cause uncertain genitals in infants.

Flutamide

There is preliminary proof for flutamide in women; however, it is associated with relatively high rates of liver problems. Like spironolactone, it is commonly only used ladies.

Certain hair shampoos and conditioners and creams creatively become thick current locks, without having affected the growth pattern. There have also been improvements in the style industry with wig design. The ornament has also been proven a source of emotional support for females going through radiation treatment, with melanoma heirs in one study explaining their wig as a “constant companion”. Other research in ladies have confirmed a more combined psychosocial effect of hairpiece use.

Specialized head tattoo designs can simulate the overall look of a short buzzed haircut. Clinical research management has always a very good scope and you can make your career in this field.

Related Topics:

1)Requirement of Clinical Research Associate

2)What is the responsibility of a clinical research associate?

Don't be shellfish...Digg thisEmail this to someoneShare on FacebookShare on Google+Buffer this pagePin on PinterestShare on LinkedInShare on RedditPrint this pageShare on StumbleUponShare on TumblrTweet about this on Twitter

What Are the Steps Related to Clinical Assessments?

Clinical assessments are a type of analysis that involve huge numbers of individuals order to test new therapies. Many, but not all analysis, are assessments.

Clinical analysis aim to find out important info in response to any adverse wellness question in a very methodical way. A well designed analysis will provide efficient evidence that can help improve NHS services and therapies and the healthcare understanding of doctors.

To be efficient it usually involves obtaining wellness details from a variety of individuals whose healthcare concerns fit the topic of the study. Where sufferers agree, or “consent”, to join as volunteers, this details might be obtained by:

  • Interviews
  • Questionnaires
  • Tests on sufferers in a healthcare setting that measure the effects of new drugs
  • Using individual records
  • A combination of the above

If you are interested in becoming a individual in research:

You could ask your GP or Advisor to consider any assessments or analysis that you may be suitable for You could check out the web pages for your local Clinical Research Network

You could check out the The UK Clinical Trials Entrance which provides details about scientific analysis assessments running in the UK

The NHS Structure says that your NHS healthcare professional should inform you of any analysis for which you may be eligible. ‘Eligible’ here concerns how you fit the strict healthcare and personal requirements used in the study design for it to work technically.

Think about it for a time that you are a effective psycho therapist. Cynthia comes to see you because she’s having a problem. How do you cure her? How do you even know incorrect with her?

Clinical assessment is a way of identifying and preparing treatment for a individual that includes analyzing someone in order to determine incorrect. There are several kinds of emotional tests, all of which have their own pros and cons.

What’s the point of assessment? To response that, let’s go back to the time that Cynthia walking into your workplace. She informs you that she’s sensation very pressured out and nervous because she keeps failing to remember factors. She used to be really up to the mark, but lately she has problems keeping in mind where she sitting her car or what she did just a couple of moments ago.

What’s incorrect with Cynthia? There are several factors that can cause forgetfulness. The only way that you can find out incorrect with her is to do some kind of assessment. Medical tests help you, the psycho therapist, to know what might be resulting in trouble for your individual. Clinical assessment example can be related to psychology.

Related Topics:

1)Requirement of Clinical Research Associate

2)What is the responsibility of a clinical research associate?

Don't be shellfish...Digg thisEmail this to someoneShare on FacebookShare on Google+Buffer this pagePin on PinterestShare on LinkedInShare on RedditPrint this pageShare on StumbleUponShare on TumblrTweet about this on Twitter

Why We Need Rigorous Study Designs For Rare Disease Clinical Trials

Why We Need Rigorous Study Designs For Rare Disease Clinical Trials

Finally FDA approved Sarepta’s eteplirsen (Exondys 51), doing this, they actually welcomed the Duchenne muscular dystrophy (DMD0 community. Though it was shrouded with some controversies.

Eteplirsen is a gene therapy drug for administration in DMD patients whose dystrophin mutation is manageable by skipping exon 51.It was approved after a thorough study of 12 patients, 4 of whom, received placebo for 24 weeks before being re-randomized to one of two dosages.There were some brow raising questions regarding the use of historical data as a control in the absence of a concurrent placebo arm of the latter part of the study and the efficacy measures used. But finally, Eteplirsen was given approval by the FDA, and though entire the process was taken over by controversy, demonstrated the power for innovations in designing a clinical trial and analytical methods.

Producing High-Quality Data

After this recent approval, and the essentials for novel clinical research in rare drug development, it might be tempting for sponsors to push boundaries such that their drugs comes to market more fast and at cheaper price. The authorities of Food and Drugs says that owing to all controversies over Eteplirsen they must multiply their efforts to propagate the therapeutic development ecosystem to apply methods that would yield high-quality data from the beginning.

Requirements for FDA Approval

There are certain criteria that need to be fulfilled to get FDA approval. This needs evidence of efficacy and clinical utility of a candidate with well accepted standards and research trial design should portray those needs. Considerable flexibility in evidentiary standards of approval has been noted by other authors in the orphan disease space, suggesting a portfolio of design options that might be possible contingent upon the nature of the product and the therapeutic target. Like other therapeutic areas, endpoints must be clearly defined and time points should be clinically practical. Although the use of historical controls can be considered as a component of the review process (like in cancer drug development), patients must be exactly matched and clinical assessments must be standardized across all contributing trial centres.  Statistics must be prospectively designed to account for all time points and dosages, and potential heterogeneity across reference trials.  Studies should be planned such that the protocol is elaborate with the endpoints; in simple words, test what you have specified.

Bringing Innovation to Trial Designs

Many ways novel ideas can be introduced to planning trials while maintaining the standards of scientific excellence.  When you have to design clinical trials for rare disease, this might include getting the most out of early phase studies.  If your access to patients is limited, make sure that every patient enrolled in the study “counts” – that even proof of concept studies are well designed and properly optimized to help lend credence to later phase studies.  Innovation can also be introduced in study design, mainly in early phase research, that mixes endpoints to reduce timelines and streamline outcomes while informing the next stages of drug development.  A classic instance of this is the mixed SAD/MAD studies that includes algorithm or model based methods of dosage escalation for the purposes of defining an operational dose range for subsequent studies.  To include, Worldwide Clinical Trials has been able to use creative designing to shorten the timelines by 4 months.

We conclude the discussion here.

In the competition of many organizations CRB Tech Solutions developed a good name. It has earned a name in providing the best training in Clinical Research.

Clinical research jobs in Pune are increasing and to meet the current demand of the proficient candidates, you should consider excelling yourself with our clinical research training program.

The Clinical Research review by CRB Tech Solutions will help and guide you in making a clinical research career in this field.

Don't be shellfish...Digg thisEmail this to someoneShare on FacebookShare on Google+Buffer this pagePin on PinterestShare on LinkedInShare on RedditPrint this pageShare on StumbleUponShare on TumblrTweet about this on Twitter

Top Hurdles For Patient Participation in Clinical Trials

Top Hurdles For Patient Participation in Clinical Trials

Today we dedicate our blog topic to the hurdles that is face during participation of patients as part of clinical research.

Huge amount of money and good amount of time is spent in enrolling patients and hence addressing the concern of the hurdles that is faced must be addressed to increase study chances and reduce failure rates.

So while designing your trial, keep these 4 barriers in mind as an attempt to prevent participant dropout and errors before they become a threat for the success of your trials:

1 Misconception:

To a patient, the clinical trial phases are full of unknowns. The patients should be detailed about the processes otherwise they might be concerned by fear of being a “guinea pig”, odds about placebo, loss of autonomy, or worries about unknown side effects.

Solution:

You need to address these concerns very early during interactions with the participant. Communicate well how each aspect of the trial is important. You should also mention the advantages of participation, like gaining access to expert medical care, knowing more about their condition, and being active players in their own health care.

2 Mistrust:

Try to understand that history saw mistrust in the medical field, mainly when dealing with minor populations.

Solution:

Be transparent with the patient about your actions and this would be helpful because it will identify and explain the study motives. Another way is that you break down if any communication barriers like language or technological literacy.

3 Logistics:

When developing and implementing a clinical trial, be practical with various aspects. In addition to achieve heights for your site staff, ensure to evaluate the trial design from the participant’s view point, like they must have a busy life and they must be considering your trial a priority in their lives. Common logistical hurdles include inability to take leave from work, transportation to and from the research site, how often they need to be present and how far they might need to travel. Whether they have kids or rely on caregivers, this factor can make things complicate in their participation.

Solution:

During the design of your trial, be mindful about what is needed of the participant. Know the barriers and try to address them as much as possible.

4 Costs:

In order to overcome logistical barriers, many patients will spend their own money to participate in a clinical trial. If your participants face delays in the payment process, they might be forced to wait for reimbursement for up to weeks at a time. With this prolonged and slow payment model, participants might be on their next trial visit before being paid for their last visit. This delay might leave the subject feeling undervalued or that the trial is not systematic, which could lead to decline in compliance and participation.

Solution:

As the participants need a variety of accommodations for logistical planning, they might also need a diverse payment options. Giving your subjects a choice on how they would like to be paid increases your site’s dedication to patient’s concern, which increases the chances of a positive experience in clinical trial. Tools like Nimblify’s Participant Payments provide a variety of payment options that could not only decrease your site’s administrative burden, but also offers other effective and diverse payment plans for participants.

Reducing these barriers to participation in a clinical trial can lead to more reliable study data, make your site more patient-centric and provide an overall better participant experience you achieve future success.

We conclude now with this discussion.

Please let us know your opinion and views on EDC and its usage in CDM in the comment section below.

In the competition of many organizations CRB Tech Solutions developed a good name. It has earned a name in providing the best training in Clinical Research.

Clinical research jobs in Pune are increasing and to meet the current demand of the proficient candidates, you should consider enhancing yourself with our clinical research training program.

The Clinical Research review by CRB Tech Solutions will guide you in considering a clinical research career in this field.

Don't be shellfish...Digg thisEmail this to someoneShare on FacebookShare on Google+Buffer this pagePin on PinterestShare on LinkedInShare on RedditPrint this pageShare on StumbleUponShare on TumblrTweet about this on Twitter

Clinical Research Industry’s Strategy to Epidemics

Clinical Research Industry’s Strategy to Epidemics

In the field of clinical research mainly epidemic response face many challenges. Clinical research done on global health concerns often needs rapid action, immediate trial start-up and lower standard good clinical practice (GCP), among many other struggles. It’s very difficult to carry out a clinical trial during the course of an epidemic. However, there are measures to overcome these challenges.

In a recent conference of Partnerships in Clinical Trials (PCT) that was held as a part of Boston Biotech Week (BWB), two inspiring presenters shared their story of journeys working to combat infectious diseases, like Ebola and Zika, in 3rd world countries. Both the presenters presented a common idea that the research industry needs to work together to become more prepared for responding an epidemic occurrence of an outbreak.

Collection of right data

Presenter Toni Hoover of Bill & Melinda Gates Foundation said on the power of technology and therapeutic innovations to fight diseases that affects underprivileged individuals. She said that their organization is dedicated to enhancing quality of life worldwide, works with many people to give vaccines and new therapies to people in poor and downtroden communities.

The Foundation and its collaborators in the biotech field are working to collect data required to make informed decisions during an epidemic. Hoover said that the data has the potential to be utilised to predict where the next epidemic might occur, pronouncing that the whole healthcare ecosystem needs to work together to prepare and develop a platform for combatting with epidemics like that of Ebola and Zika. She said that Zika is a perfect example that says the need to think about interventions, but also how preparations can be made with the help of collection of the right data to advice decisions.

Industry transparency must be increased

In the same manner, presenter Trudie Lang of the Global Health Network at the University of Oxford expressed her belief that the clinical research industry must be more prepared to respond in the event of an outbreak.

With reference, Lang shared her experience as a researcher performing an Ebola trial in West Africa. She described the hurry to begin the study and was under immense pressure to complete the trial in 16 week only. Lang said that her team was able to complete the clinical trial at rapid speed, but admitted they were too late. The epidemic already spread fast by the time the trial was complete.

This experience made Lang realise that the research community must be always ready to combat infectious diseases before an epidemic reaches a downward slope, more possibly before an outbreak occurs.

Finally Lang proposed a solution to the current problem by saying that research information must be shared and there should be transparency in clinical research industry.Lang came forward with an argument that sharing clinical research information between groups, plagued areas and regions would enhance the agility of a research enabling faster response to life-threatening diseases.

Fact is that epidemics and global diseases are significan cases for the need of organizational collaboration and information sharing. The two women and their research highlighted many aspects of clinical research that could prevent or help people in their suffering worldwide.

Now we conclude the discussion.

To learn more methods for increased industry efficiency, view our library of resources for clinical research professionals.

In the competition of many organizations CRB Tech Solutions developed a good name. It has earned a name in offering the best training in Clinical Research.

Clinical research jobs in Pune are increasing and to meet the current requirement of the proficient candidates, you should consider enhancing yourself with our clinical research training program.

The Clinical Research review by CRB Tech Solutions will help and support you in considering a clinical research career in this field.

Don't be shellfish...Digg thisEmail this to someoneShare on FacebookShare on Google+Buffer this pagePin on PinterestShare on LinkedInShare on RedditPrint this pageShare on StumbleUponShare on TumblrTweet about this on Twitter

A Dilemma For Big Pharma Companies : CNS Drugs

A dilemma for big pharma companies : CNS Drugs

The central nervous system (CNS) is the most complicated area of clinical research. And currently the big pharma companies are keen to invest in this therapeutic area. But the R&D spends have not yet got rewarded with the desired results. R&D in this area is risky and chances of approving the drugs by the regulatory board are very slim. Hence big pharma companies are at the risk of major losses.

The budget of clinical research for developing a CNS drug versus a cardiovascular drug is 30 percent higher and the chances of a CNS drug reaching a great status in the market is about 50 percent lower.

Research and development by big pharma companies in area of diseases like depression, anxiety, schizophrenia, Alzheimer’s, Parkinson’s and stroke have invited the risks of heavy investments but very less guarantee of success.

The big companies concluded that the risks associated with CNS drug development are very high—so are they justified?

Challenges Facing CNS Drug Development

External pressures have created trouble for the pharma industry’s efforts to address CNS disorders like the active “anti-psychiatry” movement made up of organisations, politicians, religious groups and layman who does not believe the importance of psychiatric treatment.

Moreover there are also the internal pressures. For instance only 8.2% of CNS drug candidates become available for clinical use, compared with 15% of other drugs. Phase II and III of clinical trials and also the regulatory approval; all takes much longer for CNS drugs compared to other therapeutic drugs. Some CNS drugs might take 18 long years from preclinical work to marketing, and clinical research organizations rarely take the benefits of available regulatory tools like Priority Review and Fast Track designation.

Phase III failures

As per reports, most CNS R&D losses of recent years are due to the fact that the majority (4 out of 5) of CNS leads fail the most crucial and expensive phase III stage of clinical trials. And reasons are numerous that includes strict board regulations for CNS disorders to insufficient understanding of the facts underlying brain disease.

What Clinical Research Organizations (CROs) Can Do?

To mention, the figures say that CNS disorder – patients outnumber that cardiovascular disorders ones and with increase in population, the numbers with CNS disorders are increasing. To address this need, there are some ways to enhance the speed of CNS drug development like; implementing proof-of-concept studies, orchestrating studies with a singular drug development team rather than by handing off studies phase by phase, and embracing open, dose-ranging trials followed by moves to a small sample, randomized clinical trial before the move to Phase III. The idea to co-develop CNS drugs with publically sponsored research institutions can also lessen the known risks involved in the development process of CNS drug.

Effective CNS drugs can lessen patient suffering, prolong longevity, improve life-quality and address public health concerns—so it’s essential for all of involved in the drug development process of CNS to look for innovative approaches in bringing these drugs from lab to the market.

We conclude here.

The fact is that disorder associated with central nervous system need to be seriously considered and effective measures in their development process should be initiated.

Amidst many organizations providing clinical research training, CRB Tech Solutions developed a good name. It has earned a name in providing the best training in Clinical Research.

Clinical research jobs in Pune are increasing and to meet the current demand of the proficient candidates, you should consider enhancing yourself with CRB’s clinical research training program.

The Clinical Research review by CRB Tech Solutions will guide you in considering a clinical research career in this field.

Don't be shellfish...Digg thisEmail this to someoneShare on FacebookShare on Google+Buffer this pagePin on PinterestShare on LinkedInShare on RedditPrint this pageShare on StumbleUponShare on TumblrTweet about this on Twitter

21 Trends for Nurse Practitioners in 2016 Part-I

21 Trends for Nurse Practitioners in 2016 Part I

Today we write this blog topic and shall continue discussing in our next upcoming blogs the same in details. In the booming story of healthcare sector the nurses have their own role and applause is credited to them.

The purpose of this blog piece is to explore 21 health care trends to watch for in 2016 that could impact nurse practitioners and help in healthcare reform and as a whole towards the health technology. Here I’m discussing a few and the rest will be discussed in our upcoming articles.

Nurse Practitioner Concerns

Changing Demographics

Conventionally the nursing profession was filled with middle-aged Caucasian females; now since the past decades, there are some demographic changes. Recent nurse graduates are more educated, with ethnic diversity and younger. Even more men are entering the profession than previous counts.

New graduates opt to choose non-clinical nursing careers in informatics, health policy, education and hospital administration. Younger nurses are more in a haste to change the profession.

Non-Nurse yet Nurse Practitioners

It is common that “non-nurse” are willing and rather practicing as nurses. Non-nurse nurse practitioners are those who work as a nurse without any previous experience as a nurse.

Physicians find these non-nurse nurse practitioners more clinically proficient than those with registered nursing experience.

Doctor of Nursing Practice

The growth of the Doctor of Nursing Practice (DNP) degree has increased everyone’s expectations.

The University of Kentucky College of Nursing began the first DNP program in 2001, which mainly targeted educating clinical executives. Today, DNP graduates are enacting a variety of roles which includes specialist clinician, primary care provider, research scientist, professor, advocate, informaticist, lobbyist, and executive.

Enhanced Autonomy

In the early part of 1980s, Oregon, Alaska, New Hampshire, and Washington were the first states to adopt more advanced legislation surrounding nurse practitioner rights

Though the physician community objected, the Institute of Medicine, Robert Wood Johnson Foundation, and Federal Trade Commission (among many others) supported legislation that permits nurse practitioners for independent practice. Independent practice has definitely reached a tipping point, with more and more state legislatures removing the outdated laws that prevent patients from receiving services from nurse practitioners.

Skytouching Salaries

The nurse practitioner salaries have increased over the decades even faster than inflation and they also surpassed their physician assistant colleagues.

Faculty Shortages

In March 2015, the AACN published an update on the scope of the nursing faculty shortage. This crisis continues to grow due to college budget constraints, an aging faculty, and job competition from clinical sites.

High Job Demand

Yet their job demand continues to rise. In 2015, the United States Bureau of Labor Statistics projected a 31% growth rate for the nurse practitioner profession compared with the average of 11% for all other careers. According to Fortune Magazine, nursing remained the most in-demand profession across the world this year, and nurse practitioner was ranked the second best job in America by U.S. News and World Report.

To be contd.

In the competition of many organizations CRB Tech Solutions developed a good name. It has earned a name in providing the best training in Clinical Research.

Clinical research jobs in Pune are increasing and to meet the current demand of the proficient candidates, you should consider enhancing yourself with our clinical research training program.

The Clinical Research review by CRB Tech Solutions will guide you in considering a clinical research career in this field.

Don't be shellfish...Digg thisEmail this to someoneShare on FacebookShare on Google+Buffer this pagePin on PinterestShare on LinkedInShare on RedditPrint this pageShare on StumbleUponShare on TumblrTweet about this on Twitter

Myths and Reality Of EDCS In Clinical Data Management

Myths and Reality Of EDCS In Clinical Data Management

Today in this blog topic we would discuss EDCS and its utility in CDM i.e. Clinical Data Management. EDCS is the acronym for Electronic data capture System.

EDC is very common in usage in clinical study yet there are so many myths and misconceptions surrounding the move from conventional, paper-based clinical data input to EDC. The only fact is that EDC technology more the cloud-based systems are comparatively a recent addition to the clinical research industry.

Though EDC is no longer a novel object, yet it is too young to be embraced as the next industry standard. EDC is caught somewhere in between.

Here we discuss the myths surrounding with it and how to overcome them.

Myth 1: EDC is expensive

Reality: EDC cuts down study costs

Some EDCS are pricey to install, train the staff and implement, but the overall budget during the study and after the study cannot be underlined. Sponsor ROI for switching to EDC is well worth the initial investment.

The very thought that EDC is expensive is a remnant of the early history of EDC. When the technology was first initiated, as with any first generation thing, the more capable the system was the more expensive it was. EDC vendors are now available, all competing to overtake in performance the other guys and that too in the most attractive price point.

Myth 2: Switching to EDC involves too much time

Reality: EDC is very precious to study time

This myth has been true when EDC got first rolled out for clinical trials, but it is entirely a baseless argument today. To mention, 80% of the time and money spent on pharma development is spent on repetitively conducting clinical trials. For your information, EDC allows both for an attractive cost ROI and time ROI too.

On an average, EDC cuts 41% of pre-study preparation time.

Myth 3: Data stored in the cloud is unsafe

Reality: Cloud storage is comparatively more secure than on-site and/or paper

We all know and heard about the urban style of cyber theft. We hear horror stories of identity theft, hacking of bank accounts, etc. Always an exception exists for the rule; data storage for the most of of cloud systems is protected with huge and redundant security protocols against loss, theft or corruption of integrity. 

Myth 4: EDC is meant for massive Phase III+ studies

Reality: Studies of every size can take advantage of EDC

Though the origin or initiation of EDC was done keeping larger studies in mind like phase 3 clinical trials or later, but currently there are systems present to match every varying degree of study be it simple ones or complex. Of course, the longer the duration and greater the number of variables measured will explain the actual value of switching to EDC.

To mention EDC systems are very much customizable. If your next clinical venture is going to have more or less data than the previous study, your EDC vendor can work with you to customize the system as per requirement, so your team does not need to spend time and effort to source another vendor.

What are the possible disadvantages of EDC for CDM?

To be honest, there is not a single scenario where EDC does not defeat or is a better choice than paper-based data management in terms of savings of time and money. EDC is even “green” compared to conventional data capture methods.

We conclude.

Please let us know your opinion and views on EDC and its usage in CDM in the comment section below.

In the competition of many organizations CRB Tech Solutions developed a good name. It has earned a name in providing the best training in Clinical Research.

Clinical research jobs in Pune are increasing and to meet the current demand of the proficient candidates, you should consider enhancing yourself with our clinical research training program.

The Clinical Research review by CRB Tech Solutions will guide you in considering a clinical research career in this field.

Don't be shellfish...Digg thisEmail this to someoneShare on FacebookShare on Google+Buffer this pagePin on PinterestShare on LinkedInShare on RedditPrint this pageShare on StumbleUponShare on TumblrTweet about this on Twitter

Top 5 Problems With Using Spreadsheets to Collect Clinical Data

Top 5 Problems With Using Spreadsheets to Collect Clinical Data Spreadsheets are very basic of a tool to maintain the increasing complexity of clinical trials. Here we write about 5 reasons to stop using them. For many people Microsoft Excel is a free and familiar tool. Spreadsheets are used for a wide range of projects, but they are far from ideal when it comes to data capture in clinical trials. Originally Excel was not created to build case report forms (CRFs) or to verify patient data that is collected in clinical trials. In spite of the technological advances in software solutions, many organizations still opt using spreadsheets. Here are five problems with using spreadsheets to collect and store data from clinical trials.

1. Lack of compliance.

If you submit your clinical trial data to the FDA, there are a number of regulatory requirements to meet such as 21 CFR Part 11. One necessary aspect is traceability of any and all the changes that are made to data. In an electronic data capture (EDC) system this is possible with audit trail functionality. If someone make changes of values in a spreadsheet, the history of who created the change, the date and time the change was made, the entered old and new values , and the reason why the change was made are not available. You simply cannot trust something that you cannot track.

CDM

2.Data is not secure.

Spreadsheets have quite a limited permission controls when it comes to confining access for multiple users. This lack of protection can lead to data manipulation, which compromises the data integrity. There are also concerns with limited storage and electronic signatures.

3. Errors are not noticed.

Though you can use basic data validation in Excel with various formulas, data entry errors can still easily go unseen. There are different types of data errors in addition to misplaced, lost, or omitted data. Even though utilizing Excel usually saves time up front because the staff uses the program and therefore do not need to be trained, a certain amount of time can be wasted on consolidating files and checking for errors.

4. No central location for forms and data.

Spreadsheets are difficult to locate if they are saved to several files and folders. Often times important data is scattered and multiple copies of a document are created. If you’re still using spreadsheets. An EDC system organizes and houses a central repository of forms, permitting them to be reused across multiple protocols. This eliminates the need to recreate commonly used forms.

5.Inefficient work-flows.

Spreadsheets are not sophisticated enough to manage clinical data and can disrupt natural work-flows. Recreating newer versions of a form can happen often in clinical research, which isn’t easy to deploy in spreadsheet format. Similarly, there is no efficient way to resolve queries using spreadsheets. An EDC system is developed to have a very logical flow for everything from form creation to query management. It also thins communication between monitors, data managers, and coordinators.

Spreadsheets are used in almost every discipline. While they can provide enough functionality for certain tasks, they don’t have the technical controls in place to collect, store, and verify clinical data.

In the competition of many organizations CRB Tech Solutions developed a good name. Its well known in providing the best training in Clinical Research.

Clinical research jobs in Pune are increasing and to meet the increasing requirement of the proficient candidates , you should consider enhancing yourself with our clinical research training institute.

The Clinical Research review by CRB Tech Solutions will guide you in considering a clinical research career in this field.

Related Posts:

1) Data entry for a clinical research
2) What is the Overview of Clinical Data Management?

Don't be shellfish...Digg thisEmail this to someoneShare on FacebookShare on Google+Buffer this pagePin on PinterestShare on LinkedInShare on RedditPrint this pageShare on StumbleUponShare on TumblrTweet about this on Twitter

Apple Plans Transform HealthKit From Tracker To Diagnosis Tool

Apple Plans Transform HealthKit From Tracker to Diagnosis Tool

Till date Apple’s HealthKit has mostly collected fitness data from its devices. In the future, if the company finds its way, the software will interpret that information, converting it into advice for users, doctors and others.

Many health care experts hired by Apple in recent years are designing enhanced electronic health record software that can well analyze and understand the implications of patient data.

The iPhone manufacturer is even working on new apps for the Apple Watch. It can track users’ sleep patterns. Another app focusses on fitness levels by calculating the time taken for the heart rate to fall from its peak to resting level. Apple already has an app that measures heart rate, but yet don’t interpret them.

The ultimate goal of Apple’s health care technology team is to turn HealthKit into a tool that improves diagnoses. The system could do away two problems that plague the field of clinical research and have stumped other specialist firms in the field.

Chief Executive Officer Tim Cook wants Apple to act more in improving software and services to secure new sources of economy and make customers more dependent on the company’s devices.

In early this year, Apple bought Gliimpse Inc., a startup that build software to pull electronic health records from different databases and in different formats and finally store them in one place.

He equated the product to Apple’s music business. That negan with the iPod, but as more people became habituated to storing all their music files digitally, Apple united all music lovers in a single platform on top of the device.

Apple health software might become a revenue driver, too, by keeping people intrigued to the company’s equipments. If a patient’s health records, and related suggestions, are reachable through Apple’s system, it would be difficult to trade in an iPhone for a smartphone running Google’s Android OS, and its health-tracking software Google Fit.

The second module of Apple’s Watch has a built-in GPS tracker, faster processor and is water resistant and many people can run, swim and do other exercise with the device. The upgraded Watch software, dubbed watchOS 3, puts health tracking information more prominently in the user interface, and adds a breathing during exercise app as well as tracking during swimming.

Building more sensors into the Watch serves a limited purpose. The accelerometer can generate most of the useful data needed to monitor a person’s well-being. A glucometer or blood-pressure sensor would only help a small percentage of users, the person said.

Scott Jenkins, said that Apple is working hard with many of these large institutions to produce tools that are medically significant, to take data from sensors.

Stephen Friend, a Merck & Co. veteran who founded health data non-profit Sage Bionetworks, is honored with being the brains behind ResearchKit. He joined Apple as full-time employee in June after working as a consultant for more than two years.

Yoky Matsuoka, formerly technology chief at Google’s Nest Labs unit, joined Apple’s health team last year. Nest mostly known as a hardware specialist, but Matsuoka head the development of software that interpreted and learned from data that its internet-connected thermostats collect.

Apple’s greatest obstacle for now is proving to medical professionals that data delivered from wearables through HealthKit and ResearchKit is reliable.

In the competition of many organizations CRB Tech Solutions developed a big name. Its better known in providing the best training in Clinical Research.

Clinical research jobs are increasing and to meet the increasing requirement of the peofecient professionals , you should consider improving yourself with our clinical research training program.

The Clinical Research review by CRB Tech Solutions will guide you in considering a clinical research career in this field.

Related Topics:

1) Top 10 Clinical Research Companies in Pune

2) Clinical Research Organization

Don't be shellfish...Digg thisEmail this to someoneShare on FacebookShare on Google+Buffer this pagePin on PinterestShare on LinkedInShare on RedditPrint this pageShare on StumbleUponShare on TumblrTweet about this on Twitter